Decreased SIRT3 expression during NAFLD could be due to palmitic acid—levels increase during obesity—that downregulates SIRT3, thus resulting in oxidative stress and apoptosis in the liver [365]. The gene discussed is SIRT3; the disease is metabolic dysfunction-associated steatotic liver disease.